Formycon AG
Liquid Formalation of a VEGF Antagonist
Last updated:
Abstract:
The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate.
Status:
Application
Type:
Utility
Filling date:
14 Jan 2020
Issue date:
30 Jul 2020